MedPath

Microvascular dysfunction in malignant hypertension; evaluation of the endothelial glycocalyx.

Conditions
hypertensive crisis
10057166
Registration Number
NL-OMON32232
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Age between 18 and 99 years
Blood pressure above 120 mmHg diastolic on repeated examination
Admission for parenteral bloodpressure lowering treatment with labetalol

Exclusion Criteria

Current pregnancy
Intoxications (e.g. cocaine, XTC)
Hypertensive crises treated with other oral or parenteral drugs than labetalol
Contra-indication for beta or alpha blockers.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Microvascular glycocalyx volume changes</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Coagulation activation<br /><br>Endothelial activation<br /><br>Glycocalyx degradation products<br /><br>Oxidative stress measurements</p><br>
© Copyright 2025. All Rights Reserved by MedPath